KLOW Blend

Quick Facts

• Full Name: KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV)
• Type: Enhanced multi-peptide synergistic blend with anti-inflammatory component
• Category: Skin Health / Anti-Aging / Wound Healing / Anti-Inflammatory / Gut Health
• Components:
  • GHK-Cu — skin remodeling, collagen, anti-aging
  • BPC-157 — tissue repair, angiogenesis, gut healing
  • TB-500 (Thymosin Beta-4) — actin regulation, tissue regeneration
  • KPV — tripeptide anti-inflammatory, gut and skin healing
• Administration: Subcutaneous injection blend / Topical
• Status: Research Only (individual components)
• WADA Status: TB-500 Prohibited (S0); BPC-157 Prohibited (S0)

What It Does

The KLOW Blend is the enhanced version of the GLOW Blend, adding KPV (Lys-Pro-Val) as a fourth component to specifically address inflammatory pathways. KPV is a tripeptide derived from alpha-MSH that targets NF-κB and mast cell activation — making the KLOW Blend particularly effective for inflammatory skin conditions (eczema, psoriasis, rosacea), IBD-associated gut-skin axis issues, and any healing context where inflammation is a primary barrier to recovery. The K in KLOW refers to KPV.

Component Overview

GHK-Cu Contribution

• Collagen I, III, elastin upregulation
• Antioxidant gene activation (SOD, catalase)
• NF-κB downregulation → anti-inflammatory

BPC-157 Contribution

• VEGFR2-Akt-eNOS angiogenesis
• Gut mucosal healing (oral bioavailable)
• GH receptor upregulation → collagen synthesis

TB-500 Contribution

• Actin sequestration → cell migration for wound closure
• Synergistic angiogenesis and anti-inflammatory action

KPV Contribution (Enhancement over GLOW)

• NF-κB pathway inhibition → broad anti-inflammatory
• Mast cell stabilization → reduces histamine/tryptase release
• Direct gut mucosal healing (oral bioavailable)
• Skin barrier repair and anti-inflammatory for dermatological conditions
• Synergizes with GHK-Cu for anti-inflammatory + remodeling

Dosing Protocols

Injectable KLOW Protocol

• GHK-Cu: 1–2 mg SubQ daily
• BPC-157: 250–500 mcg SubQ daily
• TB-500: 2–2.5 mg SubQ 2x/week (loading) → 2 mg/week (maintenance)
• KPV: 1–2 mg SubQ daily (or 500 mcg–1 mg oral for gut targeting)
• Duration: 4–6 week cycles; 2 weeks off
• Source: The Peptides Bible, Peptides Made Easy

Gut + Skin Protocol

• KPV oral (500 mcg–1 mg) + BPC-157 oral (250–500 mcg) for gut axis
• GHK-Cu topical (1–3%) + KPV topical for skin

Stacks Well With

• VIP – gut anti-inflammatory synergy (VIP + KPV + BPC-157 gut stack)
• Ipamorelin + CJC-1295 NO DAC – GH axis collagen production support
• LL-37 – antimicrobial protection alongside healing
• Thymosin Alpha-1 – immune modulation complement

Use Cases

• Inflammatory Skin Conditions (eczema, psoriasis, rosacea, atopic dermatitis)
• IBD and gut-skin axis disorders
• Wound Healing with inflammatory component
• MCAS support (KPV mast cell stabilization)
• Skin Rejuvenation with anti-inflammatory protection
• Scar Remodeling
• Anti-Aging (skin + systemic)

Contraindications & Safety

• Active malignancy — angiogenesis and growth factors; avoid
• WADA: TB-500 and BPC-157 are S0 prohibited
• Individual component safety profiles apply — see GHK-Cu, BPC-157, TB-500, KPV
• Addition of KPV generally improves safety by moderating inflammatory responses

Storage

• Individual lyophilized peptides: -20°C long-term; 2–8°C short-term
• Reconstituted: 2–8°C for 2–4 weeks; protect from light
• Mixing: Reconstitute separately; combine in syringe at time of injection or use individual sites
• Solvent: Bacteriostatic water for multi-use vials

PubMed Research

Research links will be added after PubMed search

Sources

• The Peptides Bible – Enhanced blend protocols
• Peptides Made Easy – KLOW blend dosing
• Individual peptide literature: GHK-Cu, BPC-157, TB-500, KPV

#skin-health #anti-aging #anti-inflammatory #wound-healing #gut-health #MCAS #blend #GHK-Cu #BPC157 #TB500 #KPV #peptide